Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway

Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway

Hyperuricemia is one of the independent risk factors for atherosclerotic cardiovascular disease. Herein, we investigate the association between uric acid and cholesterol metabolism and the effect of dioscin on the prevention of hyperuricemia-induced atherosclerosis. In the potassium oxonate-treated...

Full description

Bibliographic Details
Main Authors: Ruixia Bao, Wei Wang, Beibei Chen, Jujie Pan, Qian Chen, Mengyang Liu, Dan Wang, Yuzheng Wu, Haiyang Yu, Lifeng Han, Yi Zhang, Tao Wang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Nutrients
Subjects:
dioscin
tigogenin
hyperuricemia
atherosclerosis
cholesterol
bile acid
Online Access:https://www.mdpi.com/2072-6643/14/9/1983

Similar Items

Similar Items